Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women. (Q54375873)

29 May 2018

title

Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women. (English)

1 reference

29 May 2018

1 reference

1 reference

Armel Stockis

1 reference

29 May 2018

Paul Rolan

series ordinal

1 reference

29 May 2018

publication date

1 December 2013

1 reference

29 May 2018

The Journal of Clinical Pharmacology

published in

1 reference

29 May 2018

volume

1 reference

29 May 2018

issue

1 reference

29 May 2018

page(s)

1313-1321

1 reference

29 May 2018

Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)

cites work

1 reference

Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity

21 January 2018

1 reference

Brivaracetam (ucb 34714) inhibits Na(+) current in rat cortical neurons in culture.

21 January 2018

1 reference

Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial.

21 January 2018

1 reference

Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial

21 January 2018

1 reference

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males

21 January 2018

1 reference

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men

21 January 2018

1 reference

Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects

21 January 2018

1 reference

Effect of gemfibrozil on the metabolism of brivaracetam in vitro and in human subjects

21 January 2018

1 reference

Brivaracetam disposition in mild to severe hepatic impairment

21 January 2018

1 reference

Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice

21 January 2018

1 reference

Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz

21 January 2018

1 reference

Levonorgestrel. Clinical pharmacokinetics

21 January 2018

1 reference

Enzyme induction with antiepileptic drugs: cause for concern?

21 January 2018

1 reference

Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives

21 January 2018

1 reference

Pharmacokinetic interactions between contraceptives and antiepileptic drugs.

21 January 2018

1 reference

Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use.

21 January 2018

1 reference

Lamotrigine plasma levels reduced by oral contraceptives

21 January 2018

1 reference

The use of hormonal contraception among women taking anticonvulsant therapy

21 January 2018

1 reference

Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations

21 January 2018

1 reference

Hormonal effects of the 300 microgram norethisterone (NET) minipill. 2. Daily gonadotrophin levels in 43 subjects during a pretreatment cycle and during the second month of NET administration

21 January 2018

1 reference

Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs

21 January 2018

1 reference

Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women

21 January 2018

1 reference

Study of urinary 6 beta-hydroxycortisol/cortisol ratio in spot urine sample as a biomarker of 3A4 enzyme activity in healthy and epileptic subjects of Egyptian population

21 January 2018

1 reference

Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity

21 January 2018

1 reference

Poor correlation between 6beta-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity

21 January 2018

1 reference

The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids

21 January 2018

1 reference

Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy

21 January 2018

1 reference

Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug

21 January 2018

1 reference

Causes and consequences of oral contraceptive noncompliance

21 January 2018

1 reference

Epilepsy and the ovary (cutting out the hysteria).

21 January 2018

1 reference

Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects

21 January 2018

1 reference

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCPH.187

1 reference

29 May 2018

1 reference

29 May 2018